WestEnd Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$840 Hold
3
﹤0.01% 296
2026
Q1
$800 Hold
3
﹤0.01% 264
2025
Q4
$753 Hold
3
﹤0.01% 275
2025
Q3
$861 Hold
3
﹤0.01% 251
2025
Q2
$788 Hold
3
﹤0.01% 233
2025
Q1
$698 Buy
3
+2
+200% +$485 ﹤0.01% 239
2024
Q4
$229 Hold
1
﹤0.01% 240
2024
Q3
$223 Hold
1
﹤0.01% 283
2024
Q2
$204 Hold
1
﹤0.01% 262
2024
Q1
$218 Hold
1
﹤0.01% 240
2023
Q4
$227 Hold
1
﹤0.01% 227
2023
Q3
$201 Buy
+1
New +$211 ﹤0.01% 232
2023
Q1
Sell
-1
Closed -$206 221
2022
Q4
$235 Hold
1
﹤0.01% 211
2022
Q3
$0 Hold
1
﹤0.01% 251
2022
Q2
$234 Buy
+1
New +$213 ﹤0.01% 196
2022
Q1
Sell
-1
Closed -$235 202
2021
Q4
$314 Buy
+1
New +$248 ﹤0.01% 208
2021
Q3
Hold
0
206
2021
Q2
Hold
0
206

Other funds holding LH

WestEnd Advisors's LH Position: Q2 2026 in Review

WestEnd Advisors held its Labcorp (LH) position steady in Q2 2026 at 3 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #296.

WestEnd Advisors first reported a position in LH in Q4 2021 and has held it in 16 quarters since. The position peaked at $861 in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • WestEnd Advisors held 3 shares of Labcorp worth $840 as of Q2 2026.
  • WestEnd Advisors left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #296 holding.
  • WestEnd Advisors first reported a position in Labcorp in Q4 2021 and has held it in 16 quarters since.
  • WestEnd Advisors's Labcorp position peaked at $861 in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.